Mark Zuckerberg and wife Dr. Priscilla Chan recently announced a $3 billion initiative geared towards curing most of the world’s diseases called the Biohub. Through the Chan Zuckerberg Initiative, the couple managed to draw support from other billionaires and ordinary people alike in terms of funding and cooperation. Recently, the Facebook founder released a post detailing how a meeting with top scientists gave him hope that most, if not all of the world’s diseases will be gone by 2115.
The scientists in question are at the top of their fields with regards to dealing with illnesses and they come from multiple origins, including Stanford University and UC Berkeley. Heading the team is Dr. Cori Bargmann, who is a Rockefeller neuroscientist, Futurism reports.
Even with excellent brains behind the operation, the goal of eradicating even just a majority of the known diseases plaguing the world is a monumental undertaking. Much of the challenges has to do with research, which is a costly and time-consuming affair. The Biohub will take on a lot of the weight of the problems that usually prevent scientists from making swift progress, but even then, many would consider the 100-year timeline to be overly ambitious.
Zuckerberg and the team of scientists don’t seem to think so, however, and they point to the advancements that humanity has achieved in the last few decades in extending human lifespan. Global Futurist also notes how the initiative has already addressed one of the hurdles of getting to the point that they are aiming for; coordination.
There’s also the matter of the most recent innovations in medical and bioresearch to consider, which gives the lofty goals of a disease-free world a boost. There’s the new gene-editing tool called CRISPR, which is basically a starter kit for playing God. Then there’s the project called Cell Atlas, which aims to map all of the human body’s cells to address diseases that begin at the cellular level.


Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
TSMC Accuses Former Executive of Leaking Trade Secrets as Taiwan Prosecutors Launch Investigation
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Australia Releases New National AI Plan, Opts for Existing Laws to Manage Risks
Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment
CDC Shake-Up Sparks Vaccine Policy Clash Between RFK Jr. and Susan Monarez
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
OpenAI Moves to Acquire Neptune as It Expands AI Training Capabilities
Quantum Systems Projects Revenue Surge as It Eyes IPO or Private Sale
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts
Norway’s Wealth Fund Backs Shareholder Push for Microsoft Human-Rights Risk Report
Firelight Launches as First XRP Staking Platform on Flare, Introduces DeFi Cover Feature 



